Successful Treatment of Paraneoplastic Mesangioproliferative Glomerulonephritis in Mantle Cell Lymphoma Using Acalabrutinib and Rituximab

被引：0
|
作者：
Wadhera, Sarthak [1 ]
Swain, Rudra Narayan [1 ]
Saini, Shashikant [2 ]
Sekar, Arvind [3 ]
Sharma, Praveen [4 ]
Sethi, Jasmine [5 ]
Sachdeva, Man Updesh [4 ]
Malhotra, Pankaj [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Clin Hematol & Med Oncol, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh, India
[4] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh, India
[5] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh, India
来源：
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 2024年
关键词：
Mantle cell lymphoma; Mesangioproliferative glomerulonephritis; Acalabrutinib;
D O I：
10.1007/s12288-024-01922-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Acalabrutinib in mantle cell lymphoma
    Kapoor, Prashant
    Ansell, Stephen M.
    LANCET, 2018, 391 (10121): : 633 - 634
  • [2] Acalabrutinib for mantle cell lymphoma
    Witzig, Thomas E.
    Inwards, David
    BLOOD, 2019, 133 (24) : 2570 - 2574
  • [3] A Pilot Study of Acalabrutinib With Bendamustine/Rituximab Followed by Cytarabine/Rituximab for Untreated Mantle Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 12 - 12
  • [4] Safety and Efficacy of Acalabrutinib Plus Venetoclax and Rituximab in Patients With Treatment-Naive Mantle Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 6 - 7
  • [5] Paraneoplastic glomerulonephritis and kidney infiltration by mantle cell lymphoma: A diagnostic challenge
    Lerma-Verdejo, Ana
    Monroy-Condori, Maribel
    Guerra-Torres, Xavier E.
    Paredes, Nahir Daniela Moreno
    Egea, Anastasio Serrano
    Diaz, Francisco
    Morales-Montoya, Jorge L.
    Vega, Jacobo Galan
    Arenas-Moncaleano, Ivan
    Ramos, Fernando Solano
    JOURNAL OF HEMATOPATHOLOGY, 2024, : 237 - 244
  • [6] Acalabrutinib for adults with mantle cell lymphoma
    Jurczak, Wojciech
    Dlugosz-Danecka, Monika
    Wang, Michael
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (03) : 179 - 187
  • [7] An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma
    Morabito, Fortunato
    Recchia, Anna Grazia
    Vigna, Ernesto
    Botta, Cirino
    Skafi, Mamdouh
    Abu-Rayyan, Mohammed
    Atrash, Moien
    Galimberti, Sara
    Morabito, Lucio
    Al-Janazreh, Hamdi
    Martino, Massimo
    Cutrona, Giovanna
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) : 29 - 38
  • [8] Safety and Efficacy of Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naive (TN) Mantle Cell Lymphoma (MCL)
    Wang, Michael
    Robak, Tadeusz
    Maddocks, Kami J.
    Phillips, Tycel
    Smith, Stephen D.
    Gallinson, David
    Calvo, Roser
    Wun, Chuan-Chuan
    Munugalavadla, Veerendra
    Jurczak, Wojciech
    BLOOD, 2021, 138
  • [9] Use of acalabrutinib in patients with mantle cell lymphoma
    Awan, Farrukh T.
    Jurczak, Wojciech
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (06) : 495 - 502
  • [10] A Pilot Study of Acalabrutinib with Bendamustine/Rituximab Followed By Cytarabine/Rituximab (R-ABC) for Untreated Mantle Cell Lymphoma
    Guy, Daniel
    Watkins, Marcus
    Wan, Fei
    Bartlett, Nancy L.
    Cashen, Amanda F.
    Fehniger, Todd A.
    Ghobadi, Armin
    Mehta-Shah, Neha
    Kahl, Brad S.
    BLOOD, 2020, 136
12345